---
title: "ProMIS Neurosciences, Inc. (PMN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PMN.US.md"
symbol: "PMN.US"
name: "ProMIS Neurosciences, Inc."
industry: "Biotechnology"
---

# ProMIS Neurosciences, Inc. (PMN.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.promisneurosciences.com](https://www.promisneurosciences.com) |

## Company Profile

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets kn...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.12 | 205/605 | 7.47 | 7.00 | 6.60 |
| PB | 3.57 | 261/605 | 3.10 | 1.90 | 1.55 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-05T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 50% |
| Overweight | 2 | 50% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 16.09 |
| Highest Target | 49.53 |
| Lowest Target | 18.24 |

## References

- [Company Overview](https://longbridge.com/en/quote/PMN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PMN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PMN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.